O’Donnell JT, Vogenberg FR. The Opioid Crisis and What Has Been Learned. P T. 2019;44(12).
So much to write, so little space.
A real challenge for healthcare professionals (HCPs) and responsible healthcare organization operating committees like P&T is walking back care delivery and pharmaceutical prescribing practices that have existed for more than a century.
Numerous lawsuits have been brought and some settled in 2019 already against manufacturers or distributors of opioid products. Such legal actions have brought together numerous diverse stakeholders that sought to toughen stances on promotional practices as well as utilization by HCPs in all care delivery or management settings. As a result, swift action by the judicial system and law enforcement led to rapid action among care delivery, HCPs, managed care, and the drug supply chain to toughen criteria around the appropriate use of opioids.
To provide an historical perspective along with establishing where the healthcare marketplace is at in late 2019 regarding opioid use, this article explores both and addresses what to expect going forward.
Read the full article here https://pharmaconsultantinc.com/wp-content/uploads/2020/05/The-Opioid-Crisis-and-What-Has-Been-Learned-_-PT-Community-4412-2019.pdf